Born in 1952
B.Sc. in Economics, University of Copenhagen.
Profession: Independent Advisor, Consultant and Board Member.
Other Assignments: Chairman of the Board in Atlas Antibodies AB and Genovis AB. Board Member of Boule Diagnostics, Medistim AS and Advanced Instruments Inc.
Born in 1956
Ph.D. in Medical Chemstry, Uppsala University.
Profession: Managing Director.
Other Assignments: Board Member of Pepticore and Red Glead Discovery.
Born in 1955
M.Sc. Mechanical Engineering, Royal Institute of Technology, Stockholm. Management studies at IHM, Stockholm.
Profession: Entrepreneur.
Other Assignments: Chairman of the Board of Boule Diagnostics AB, Bioworks Technologies AB, Sophion A/S, Grönsöö Säteri AB and Färjsundet Industri AB.
Born in 1962
PhD. University of Oxford.
Profession: Professor
Other Assignments: Academic
Born in 1962
Master of Science in Biophysics University of Minnesota, U.S.A.
Bachelors degree in Physics Gustavus Adolphus College, U.S.A.
Profession: Board Member and Investor.
Other Assignments: Chairman of the Board in Tobii Dynavax AB and Artificial Solutions International AB. Board Member of Nolato AB, Cellavision AB, C-Rad AB, E Öhman Fonder AB and Industrifonden.
Born 1962.
Master of Science, Danish Technical University and MBA, INSEAD.
Board member since 2020 at Vitrolife.
Other assignments: CEO of Philips Capital.
Previous assignments: Senior management positions in Philips, Sanofi and Biogen. Board member of MEDA, Orifarm, Danish Technical University/SCION, EKF: Danish Export Credit Fund (Ministry of Foreign Affairs)
Born in 1977
Ph.D. in Chemistry, University of South Carolina
Profession: Global Product Manager, Analytical
Employee Since: 2015
Born in 1973
M.S. in Computer Science and Engineering, Luleå Technical University
Profession: System Architect
Employee Since: 2018
The Board of Directors is ultimately responsible for the management and the organization of the Company. The board of directors shall consist of no fewer than five and no more than nine directors elected by a General Meeting of shareholders. Swedish law allow for the relevant trade unions to appoint two Directors and two Deputy Directors.
The Directors are appointed at the Annual General Meeting for a period of one year, i.e. up and until the next Annual General Meeting. Any vacancy in the Board of Directors may only be replaced through a resolution passed by the shareholders. The trade unions representing the employees at the Company may decide the term of the seat for their Board of Director representatives. The term for the employee representatives may, however, not exceed four years, but each such term may be prolonged without any limitation.
Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development and diagnostics, analytical testing and water and environmental testing.
Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited.
Our customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.
Biotage is headquartered in Uppsala in Sweden and employs 497 people worldwide. The Group had sales of 1,232 MSEK in 2021 and our products are sold in more than 80 countries. Biotage’s share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm.
Copyright © 2023 Biotage
Biotage är ett Globalt Impact Tech företag som är djupt engagerade i att lösa samhällsproblem. Vi erbjuder lösningar för kunders arbetsflöden inom forskning och tillverkning av läkemedel och diagnostik, analytisk testning och vatten- och miljöanalyser.
Biotage bidrar till hållbar vetenskap och vi strävar efter att göra världen mer hälsosam, grönare och renare för mänskligheten – HumanKind Unlimited.
Våra kunder spänner över ett brett spektrum av marknadssegment från läkemedel, bioteknik, diagnostik, kontraktsforskning och kontraktstillverkning till kliniska, forensiska och akademiska laboratorier liksom organisationer som fokuserar på livsmedelssäkerhet, rent vatten och miljömässig hållbarhet.
Biotage har huvudkontor i Uppsala, Sverige, och har 497 anställda världen över. Koncernen hade en försäljning på 1 232 miljoner kronor 2021 och våra produkter säljs i mer än 80 länder. Biotages aktie (BIOT) är noterad på NASDAQ Stockholm, Large Cap.
Copyright © 2020 Biotage
SEL-2EV
Two Channel, Extended Collection Bed, UV Detector